World Health Organization (WHO)

Seven countries, which include Angola, Bangladesh, the Democratic Republic of the Congo, Nigeria, South Sudan, Sudan and Yemen, accounted for about 90% of reported cases and deaths.

WHO bases its recommendations on surveillance data collected through the Global Influenza Surveillance and Response System (GISRS), supported by collaborating centres and essential regulatory laboratories.

The assessment identified strengths and areas for improvement, while the technical sessions gave EFDA experts practical experience relevant to meeting WHO requirements.

Participants included researchers, scientific leaders, women scientists, and private sector representatives, reflecting the diversity of Ghana’s research community.

In its new publication, WHO Guidelines on Expanding Contraceptive Options, WHO provides countries with evidence-based recommendations to broaden access to contraceptive methods and offer more flexibility in how people use them.

The new equipment will support a range of academic and institutional activities at the school. These include data analysis, research, lectures, seminars and virtual engagements.

The allocation forms part of an initial release of 70,000 Ervebo doses to the Democratic Republic of the Congo (DRC).

The five-day meeting in Geneva focused on developing the Pathogen Access and Benefit-Sharing (PABS) annex to the WHO Pandemic Agreement, with governments working towards a system that is practical, equitable and feasible to implement.

WHO Representative to Ethiopia, the African Union and the United Nations Economic Commission for Africa, Professor Francis Chisaka Kasolo, held a bilateral meeting with EFDA Director General Heran Gerba to discuss measures to improve health product regulation.

It builds on an earlier MoU signed by the two organisations in 2022 and sets out areas for deeper collaboration on health system strengthening and emerging health challenges.